
Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%
Dividend income offers a great way to strengthen your overall financial position. It can potentially make you less dependent on the income you earn from a job, maybe even allowing you to work less or retire earlier than planned. Money doesn't buy happiness, but being less dependent on work to fund your lifestyle could be a contributor to a happier, less stressful life.
A great way to build up dividend income is to invest in high-yielding dividend stocks that also happen to be lower-risk investments. Pfizer (NYSE: PFE), Realty Income (NYSE: O), and Bank of Nova Scotia (NYSE: BNS) are three attractive investments that you'll want to consider if you want to create a strong portfolio of income-generating stocks.
Pfizer
If you're looking for a high-yielding stock to hold for the long term, Pfizer is one you'll want to strongly consider. At 7.4%, its yield right now is more than five times what you'd get with the average stock on the S&P 500, which pays about 1.3%.
Pfizer's stock is trading down more than 10% this year (as of the end of last week), as it can't seem to catch a break. While its valuation is modest -- it trades at 17 times its trailing earnings -- concerns about healthcare reform and the company's future growth prospects have made investors uneasy about the business and investing in it.
But the healthcare company is still doing well and is on track to hit its guidance, which calls for revenue between $61 billion and $64 billion this year (comparable to how it did last year). It is also slashing costs to improve its bottom line. And it has been less than two years since it acquired oncology company Seagen, which may unlock more long-term growth for Pfizer in the future. Last year, the company also obtained approval from regulators for its first gene therapy in the U.S. -- Beqvez, a treatment for a genetic bleeding disorder.
There's some uncertainty and risk with Pfizer, but there are opportunities as well. And at such a modest valuation, now can be an excellent time to add it to your portfolio. Pfizer has been a big name in healthcare for decades, and I don't think that's likely to change anytime soon.
Realty Income
One dividend stock I think all income investors should consider owning is Realty Income. This is a real estate investment trust (REIT) that not only offers a high yield of 5.8%, but it also pays a dividend every month. There's no need to wait around for multiple months, as is the case with other dividend stocks; with Realty Income, you're getting a much more regular stream of cash flow.
The REIT has a diverse mix of tenants, which makes it an ideal option for long-term investors. It's diversified across industries and geographies, with more than 1,500 clients across 91 industries.
The dividend remains well supported -- the REIT reported funds from operations (FFO) per share of $1.05 during the first three months of the year (versus $0.94 a year ago). That averages out to $0.35 per share per month, which is higher than the rate of its monthly dividend of $0.2685.
REITs use FFO to assess how much they can afford to pay in dividends, and with Realty Income's financials looking solid, there aren't any significant risks with its payout. Share prices of Realty Income are up 5% this year, and this can be a great income-generating investment to add to your portfolio for the long haul.
Bank of Nova Scotia
Rounding out this list of high-yielding dividend stocks is Canada-based Bank of Nova Scotia, also known as Scotiabank. At around 6%, that's a high payout for a top bank stock that is known for long-term stability. It declared its first dividend back in 1833 and has continued making regular payments since then.
The bank increased its provision for credit losses in its most recent quarter, in a sign of growing concern about macroeconomic conditions. Scotiabank's net income totaled over $2 billion Canadian dollars for the period ending April 30, which was nearly identical to its bottom line in the prior-year period. There are concerns about how the Canadian economy may perform in the near future due to tariffs, but in the grand scheme of things, that may prove to be a short-term concern for investors who are willing to hang on for years. Scotiabank's impressive track record and resilience over the years should inspire some confidence in the business.
The bank stock has increased its dividend by more than 22% in four years and can be an excellent option to hang on to for the long term. Not only can you collect a high yield today, but the dividend income you get from this investment can rise over the years.
Should you invest $1,000 in Pfizer right now?
Before you buy stock in Pfizer, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,102!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $882,344!*
Now, it's worth noting Stock Advisor 's total average return is996% — a market-crushing outperformance compared to174%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of June 9, 2025
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
14 minutes ago
- Globe and Mail
2 Popular AI Stocks to Sell Before They Drop 30% and 55%, According to Select Wall Street Analysts
We are more than two years into the artificial intelligence trade, and Palantir Technologies (NASDAQ: PLTR) and Nvidia (NASDAQ: NVDA) have been standout performers. Their share prices since January 2023 have increased 2,000% and 875%, respectively. But certain Wall Street analysts think it's time to sell. Brent Thill at Jefferies has a sell rating on Palantir. His target price of $60 per share implies 55% downside from the current share price of $136. Jay Goldberg at Seaport Research has a sell rating on Nvidia. His target price of $100 per share implies 30% downside from its current share price of $143. Wall Street seems to agree with Brent Thill where Palantir is concerned. The median target price among 28 analysts is $110 per share, which implies 19% downside. But Jay Goldberg has the lone sell rating on Nvidia, and the median target price among 69 analysts is $175 per share, which implies 22% upside. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Here's what investors should know about Palantir and Nvidia. Palantir Technologies: 55% implied downside Palantir develops analytics platforms that help customers make sense of complex information. Its software drives efficiency with nuanced insights that improve operational decision-making. That value proposition is relevant across virtually every industries. Palantir helps banks prevent fraud, manufacturers fortify supply chains, retailers optimize inventory, and defense agencies track and target enemy combatants. Several independent analysts recently recognized the company as a technology leader in artificial intelligence and machine learning software. "Palantir is quietly becoming one of the largest players in this market," wrote Mike Gualtieri at Forrester Research. And CEO Alex Karp says unique software architecture makes Palantir one of the only companies that can move AI projects from prototype to production. Palantir reported solid first-quarter financial results. Revenue increased 39% to $884 million, the seventh consecutive acceleration. And non-GAAP net income increased 62% to $0.13 per diluted share. Additionally, the company raised full-year guidance, such that revenue is now projected to grow 36% in 2025. Management said demand for its artificial intelligence platform was a key tailwind. Brent Thill at Jefferies has consistently praised Palantir for its technology and execution. "It's a great company. I'm not disputing the fundamentals," he said. But Thill has a problem with the valuation. Palantir has a forward price-to-sales (PS) ratio above 80, which makes it the most expensive software stock on the market. In fact, Thill says its price could fall 70% and it would still be the most expensive software stock. Here's my take: I agree wholeheartedly. Palantir is an excellent business that could be worth more in the future. But the risk-reward profile is skewed toward risk today. Shareholders could suffer huge losses if the broader stock market loses momentum or Palantir fails to meet lofty expectations. The most prudent strategy is to trim large positions and avoid buying shares until the valuation is tolerable. Nvidia: 30% implied downside Graphics processing units (GPUs) accelerate complex data center workloads like training machine learning models and running artificial intelligence applications. Nvidia makes the most coveted GPUs on the market. They are not only faster than products from other chipmakers, but also Nvidia has created an unparalleled ecosystem of software tools called CUDA to support developers. Nvidia reported encouraging financial results in the first quarter of fiscal 2026, which ended in April. Revenue rose 69% to $44 billion amid persistent demand for AI infrastructure, and non-GAAP net income increase 33% to $0.81 per diluted share. Importantly, the bottom line increased more slowly than the top line due to the production ramp of the Blackwell chip and inventory write-downs related to export restrictions. Jay Goldberg at Seaport Research recently discussed his sell rating on Nvidia with Yahoo Finance. "It's a good company that makes great products," he noted. "But they have said already their newest line of products, the Blackwell line, is sold out for the year." That leaves little room for upside in his estimation because Nvidia will be hard pressed to beat consensus estimates if it's capacity constrained. So, bias shifts to the downside. Goldberg also noted increasingly severe export controls imposed by the Biden and Trump administrations. Initially, Nvidia was unable to sell its most advanced products to China, but newer restrictions effectively bar the company from doing any business in the country. CEO Jensen Huang says the export controls have been a failure, and Nvidia will miss out on hundreds of billions of dollars in revenue. While I think Goldberg is right to be concerned about export restrictions, I am less worried about Blackwell GPUs being sold out this year. The market will likely look past temporary capacity constraints so long as the underlying demand appears strong. Also, Wall Street expects Nvidia's earnings to increase at 40% annually through fiscal 2027, which ends in January 2027. That makes the current valuation of 45 times earnings look reasonable. Here's my take: I think patient shareholders should sit tight. I see no reason to sell Nvidia. The semiconductor industry is cyclical, which can lead to prolonged drawdowns in the stock, but the investment thesis is solid. Data center GPU sales are expected to increase at 29% annually through 2030, and AI spending is forecast to grow at 36% annually over the same period. Nvidia is ideally positioned to benefit. Should you invest $1,000 in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,871!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $875,479!* Now, it's worth noting Stock Advisor 's total average return is998% — a market-crushing outperformance compared to174%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025

Globe and Mail
14 minutes ago
- Globe and Mail
Canada's financial regulators need to reduce money laundering. A task force review might speed that up
Canada's financial regulators are about to find themselves in the hot seat. The Financial Action Task Force (FATF), a global body that sets standards to combat money laundering and terrorist financing, is conducting a review of Canada's efforts to combat financial crime. One topic that will figure prominently in that evaluation is the effectiveness of regulators, including the Financial Transactions and Reports Analysis Centre of Canada – the federal financial intelligence unit – and the Office of the Superintendent of Financial Institutions – the country's top banking regulator. Both FinTRAC and OSFI, as they are known for short, are responsible for supervising the anti-money laundering compliance of banks. The FATF has cited issues with Canada's approach to regulation, supervision and monitoring in past reviews, but this year's evaluation comes in the wake of financial-crime scandals including one involving Toronto-Dominion Bank. 'Supervisors play a crucial role in preventing money laundering and terrorist financing,' states the FATF's guidance. 'Effective supervisors also ensure that these businesses comply with their anti-money laundering and counter-terrorist financing obligations and take appropriate action if they fail to do so.' The FATF's last review of Canada in 2016 recommended that FinTRAC and OSFI co-ordinate more effectively on the supervision of banks. Specifically, it said FinTRAC had increased its supervisory capacity but still had 'somewhat limited' expertise about banking, adding OSFI was conducting its supervision with limited resources. Ottawa to overhaul financial-crime laws in new border security bill Recent money laundering scandals, however, have caused both FinTRAC and OSFI to lose face. Last fall, TD became the first bank in the United States to plead guilty to conspiracy to commit money laundering and the largest bank in U.S. history to plead guilty to failing to maintain an anti-money laundering (AML) program that complies with federal regulations. American banking regulators and the U.S. Department of Justice imposed more than US$3-billion in fines and various non-monetary penalties. The Federal Reserve Board also required the Canadian bank to relocate to the United States the parts of its anti-money laundering compliance program that are responsible for complying with U.S. law. 'This program will be subject to oversight by U.S. regulators,' stated its release. Months before publicly announcing that requirement, U.S. regulators privately questioned their Canadian counterparts about why they previously failed to spot and remedy problems with TD's anti-money laundering risk controls, The Globe and Mail reported in May 2024. On Thursday, meanwhile, The Wall Street Journal reported that Norway's US$1.9-trillion sovereign wealth fund was placing TD 'under observation' for four years over financial-crime concerns. There have also been separate allegations of wrongdoing involving Wealth One Bank of Canada and the Industrial and Commercial Bank of China (Canada). As a result, OSFI's stop-start approach to supervising financial-crime compliance in recent years will naturally be probed by the FATF. OSFI returned to AML oversight in 2024 after taking a three-year hiatus. In 2021, OSFI rescinded its guidance on deterring and detecting money laundering and terrorist financing, and handed over its regulatory responsibilities to FinTRAC. At the time, the objective was to make FinTRAC the exclusive overseer of banks' financial-crime compliance obligations. Task force to evaluate Canada's ability to fight money laundering and terrorist financing But OSFI did an about-face in 2024. Not only did it issue a new integrity and security guideline, but it stressed that it considers money laundering and the financing of terrorism third-party and foreign-interference risks that could harm the safety or soundness of banks. Trouble is, banks are once again confused about which federal regulator is in charge. They are also understandably frustrated that their massive spending on compliance programs has failed to yield successful convictions in court. Total financial-crime compliance costs for financial institutions hit US$2-billion in Canada, according to a 2023 study conducted by Forrester Consulting on behalf of LexisNexis Risk Solutions. Regulators, meanwhile, are also suffering from a breakdown in trust with the public because they operate behind a veil of secrecy. And, unlike their U.S. counterparts, they are barred from discussing problems at individual banks – even the widely publicized case involving TD. 'I would like to be forthcoming about our involvement in this case because I think that information would contribute to public confidence in the Canadian financial system,' OSFI Superintendent Peter Routledge told a Parliamentary committee in November. 'That said, Canadian law prohibits me or any OSFI official from disclosing confidential information obtained from federally regulated financial institutions in the course of OSFI's regulation and supervision activities.' Recent money laundering scandals have provided a withering assessment about the effectiveness of Canada's regulators. Maybe the FATF will finally persuade Ottawa to set them up for success.


Globe and Mail
14 minutes ago
- Globe and Mail
Inside job
Investigation When an account gets hacked, social media giant Meta offers little support, spawning a shadowy network of brokers and Meta employees who profit from helping them get back online Kathryn Blaze Baum Alexandra Posadzki Financial and cybercrime reporter The Globe and Mail Illustration by The Globe and Mail/istock to view this content.